Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,517.31
(
-0.02%
)
US TECH 100
29,174.20
(
-0.13%
)
Dow Jones
50,553.69
(
0.18%
)
Brent Oil
93.34
(
-3.76%
)
Bitcoin
74,846.08
(
-1.32%
)
News Focus
News Focus
Post# of 4522
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

ronpopeil

Send PM Follow Ignore
Followers 123
Posts 8886
Boards Moderated 0
Alias Born 10/05/2004

ronpopeil

Re: vip1999 post# 1347

Tuesday, 03/13/2012 3:02:42 PM

Tuesday, March 13, 2012 3:02:42 PM

Post# of 4522
The company seems to be exploring ways 302 can be used to treat other diseases. It would be very interesting if they start to sign deals with other big pharmas. Yes, Merck has signed a deal for 302 in pancreatic cancer (well, at least in Europe) but what about lung cancer, AML etc? The ceo said that 302 is being explored for many other indications. This could be a huge cash machine

"Don't worry about the world coming to an end today. It's already tomorrow in Australia"

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today